• Professional AI Engineer

  • Accessible to High Quality Data

  • Minimize Gap between Advancing
    AI Technology and End Users' Needs

  • End User
    = Doctor

Al Diagnostic Solutions Company where clinicians take the lead of establishment & participate along the way

"Clinical AI"

Heuron Co., Ltd. is a medical AI development company estblished in 2017 providing treatment solutions for central nervous system disorders, based on the AI model implementing clinical specialists' diagnostic insights. More than 20 clinical data-centered diagnostic programs are currently under development for such disorders as Parkinson’s Disease, Dementia, Stroke and Brain tumors​. Heuron’s research & development are led by specialists under the direction of Chairman Donghoon Shin (MD, PhD).

As modern society enters “super-aging” status, the number of central nervous system disorders occurrence is increasing each year. There are no clear dedicated diagnostic methods and treatments for the above mentioned diseases. Hence, the future demand for new drug development, applications of AI-based software, and innovative technology for the prevention & treatment of central nervous system disorders will increase rapidly. (Journal of the Korean Society of Radiology, March/2019).

We have developed and launched AI software enabling early diagnosis of degenerative disease of the brain. Whereas, the current medical image (CT, MRI) reading for central nervous system disorders have not been standardized. We are confident that this technology will reduce the time and cost of new drug development for central nervous system disorders and increase the success rate of clinical trials.


  • 2021.05

    Brain image detection and diagnosis support software(mPDia) and Medical Image Analysis Device Software (Veuron-Brain-pAb, Veuron-Brain-clS, Veuron-Brain-mN1) obtained CE certification

  • 2021.03

    Completed MFDS(Class III ) certification for brain image detection and diagnosis support software (Veuron-Brain-mPDia)

  • 2021.02

    Obtained NET(New Excellent Technology) certification for Nigrosome biomarker discovery technology in MR imaging for Parkinson’s Disease by Ministry of health and welfare

  • 2021.01

    Obtained US FDA approval of Korea’s first dementia analysis Software (Veuron-Brain-pAb)

  • 2020.07

    Obtained MFDS (Class II) certification from for Medical Image Analysis Device Software (Veuron-Brain-pAb)

    Designated as No.3 Innovative Medical Device by the MFDS (Veuron-Brain mPDia)

  • 2020.05

    Obtained Obtained MFDS (Class II) certification for Medical Image Analysis Device Software (Veuron-Brain-mN1, Veuron-Brain-cIS)

  • 2017.11

    Heuron Co., Ltd., (former) BnG Health Co., Ltd. established